Infectious Disease and Microbiology – Vibrio Species

Overview

Vibrio species are Gram-negative, curved or comma-shaped bacilli that are strongly associated with marine and brackish-water environments. Human infection commonly follows consumption of raw or undercooked seafood, particularly oysters and other shellfish, or exposure of an open wound to seawater.

Major clinical syndromes include gastroenteritis, wound infection, and bloodstream infection. Vibrio vulnificus is particularly important because it can cause rapidly progressive necrotizing soft-tissue infection and fulminant sepsis, especially in patients with chronic liver disease or iron overload.

Classification

Genus: Vibrio

Important species include:

• V. alginolyticus

• V. cholerae non-O1 strains

• V. cincinnatiensis

• V. fluvialis

• V. furnissii

• V. mimicus

• V. parahaemolyticus

• V. vulnificus

Some organisms listed under older Vibrio nomenclature have subsequently undergone taxonomic reclassification.

Microbiologic Characteristics

Vibrio species are generally:

• Gram-negative bacilli

• Curved or comma-shaped

• Motile

• Oxidase-positive

• Facultatively anaerobic

• Associated with aquatic environments

Many clinically important species are:

Halophilic

meaning they grow particularly well in environments containing salt.

High-Yield Microbiology Pattern

Curved Gram-negative rod

• ●

Oxidase positive

• ●

Saltwater

• ●

Raw seafood

→ Think VIBRIO

Incubation Period

For enteritis caused by many Vibrio species, symptoms generally develop approximately:

24 HOURS

after exposure.

The source gives a range of:

5–92 hours

depending on the species and exposure.

Epidemiology

Vibrio organisms are widely distributed in:

Seawater and coastal environments

They are particularly associated with:

• Warm coastal waters

• Brackish water

• Shellfish

• Marine animals

Human infections occur more frequently during:

Warmer months

when environmental concentrations of Vibrio may increase.

Major Food Exposure

The highest-risk foods include raw or undercooked:

• Oysters

• Clams

• Mussels

• Other shellfish

Filter-feeding shellfish can concentrate Vibrio organisms from surrounding water.

High-Yield Exposure Pattern

Raw oysters

• ●

Acute gastroenteritis

or

Severe sepsis

→ Think VIBRIO

Transmission

Two major routes of infection are:

1. Ingestion

Eating contaminated:

Raw or undercooked seafood

↓

Gastrointestinal infection

and, in susceptible patients, potentially:

Bloodstream infection

2. Wound Exposure

Open wound

• ●

Seawater or contaminated marine exposure

↓

Cellulitis / wound infection

↓

Potential:

Necrotizing soft-tissue infection and sepsis

Major Clinical Syndromes

Vibrio species can cause:

• Gastroenteritis

• Wound infection

• Cellulitis

• Necrotizing soft-tissue infection

• Bacteremia

• Severe sepsis

The specific clinical pattern varies considerably by species.

Vibrio parahaemolyticus

Vibrio parahaemolyticus is particularly associated with:

SEAFOOD-ASSOCIATED GASTROENTERITIS

Typical exposure:

Raw or undercooked seafood

especially shellfish.

Clinical Features

Patients may develop:

• Watery diarrhea

• Abdominal cramps

• Nausea

• Vomiting

• Fever

• Headache

Most gastrointestinal infections are:

Self-limited

High-Yield Pattern

Raw seafood

• ●

~24-hour incubation

• ●

Watery diarrhea and abdominal cramps

→ Think VIBRIO PARAHAEMOLYTICUS

Vibrio vulnificus

Vibrio vulnificus is the most important species in this group for:

FULMINANT SEPSIS AND NECROTIZING WOUND INFECTION

It is strongly associated with:

Raw oysters + seawater exposure

Major Risk Factors for Severe V. vulnificus Infection

Severe infection occurs disproportionately in patients with:

CHRONIC LIVER DISEASE

Other important risk factors include:

• Cirrhosis

• Alcohol-associated liver disease

• Hemochromatosis or iron overload

• Immunocompromising conditions

• Diabetes

• Older age

Why Iron Matters

V. vulnificus can proliferate particularly effectively when:

Available serum iron is increased

This helps explain its strong association with:

Iron overload and severe liver disease

High-Yield Risk Pattern

Cirrhosis

• ●

Raw oysters

• ●

Rapid septic shock

• ●

Hemorrhagic bullous skin lesions

→ Think VIBRIO VULNIFICUS

Primary Septicemia

After ingestion of contaminated seafood, particularly raw oysters, susceptible patients may develop:

PRIMARY V. VULNIFICUS SEPTICEMIA

Manifestations may include:

• Fever

• Chills

• Hypotension

• Septic shock

• Rapidly progressive skin lesions

• Bullae

• Tissue necrosis

This is a:

Medical emergency

Hemorrhagic Bullae

A classic manifestation of severe V. vulnificus infection is:

HEMORRHAGIC BULLAE

These may occur with:

• Cellulitis

• Ecchymosis

• Severe edema

• Rapid tissue necrosis

This finding in a patient with liver disease and marine exposure is an especially important diagnostic clue.

Necrotizing Soft-Tissue Infection

An open wound exposed to seawater can lead to:

Rapidly progressive wound infection

which may evolve into:

NECROTIZING SOFT-TISSUE INFECTION

Severe pain, rapidly spreading erythema, bullae, systemic toxicity, or tissue necrosis requires:

Urgent surgical evaluation

High-Yield Wound Pattern

Open wound

• ●

Warm seawater exposure

• ●

Rapid cellulitis

• ●

Hemorrhagic bullae / necrosis

→ Think V. VULNIFICUS

Vibrio alginolyticus

V. alginolyticus is particularly associated with:

Marine exposure

and may cause:

• Wound infections

• Otitis externa

• Other superficial infections following seawater exposure

Non-O1 Vibrio cholerae

Non-O1 strains of V. cholerae can cause:

Gastroenteritis

and occasionally:

Extraintestinal or invasive infection

They should be distinguished from the epidemic cholera-associated strains responsible for classic cholera.

Diagnosis

The principal diagnostic method is:

CULTURE

Appropriate specimens depend on the syndrome and may include:

• Stool

• Blood

• Wound specimens

• Tissue specimens

Laboratory Characteristics

Important laboratory clues include:

Curved Gram-negative bacillus

• ●

Oxidase-positive reaction

• ●

Marine exposure

Selective media such as:

TCBS agar

can be useful for isolation of Vibrio species from appropriate specimens.

Treatment of Gastroenteritis

For uncomplicated gastroenteritis, the most important treatment is:

FLUID AND ELECTROLYTE REPLACEMENT

This may involve:

• Oral rehydration

• Electrolyte replacement

• Intravenous fluids when dehydration is severe

Many uncomplicated Vibrio gastroenteritis infections are self-limited.

Antimicrobial Treatment

The source lists:

DOXYCYCLINE

as an important antimicrobial option.

Additional agents listed include:

• Fluoroquinolones

• Aminoglycosides

• Chloramphenicol

• Third-generation cephalosporins

• Carbapenems

Antimicrobial choice depends on:

Species + infection severity + infection site + susceptibility

Severe Vibrio vulnificus Infection

Severe V. vulnificus infection requires:

Immediate antimicrobial therapy

along with aggressive supportive management.

The source notes synergy with:

Minocycline + cefotaxime

for serious infections.

Tetracycline-class therapy combined with an appropriate broad-spectrum agent has historically been important in severe disease.

Surgical Management

Antibiotics alone may be insufficient when V. vulnificus causes:

Necrotizing soft-tissue infection

Management may require urgent:

• Surgical exploration

• Debridement of necrotic tissue

• Drainage

• Repeated surgical procedures when necessary

Critical Clinical Principle

DO NOT DELAY SURGERY FOR NECROTIZING INFECTION

Rapidly progressive V. vulnificus wound disease requires:

Antibiotics + urgent surgical source control

Vibrio vs. Aeromonas

Both may cause:

Water-associated wound infections and gastroenteritis

Vibrio

→ Primarily saltwater/brackish water

→ Raw oysters and seafood

→ V. vulnificus → liver disease + hemorrhagic bullae + sepsis

Aeromonas

→ More strongly associated with freshwater

→ Wound infections after freshwater trauma

→ Gastrointestinal disease also possible

Memory Aid

VIBRIO = SEA

Think:

V = Vibrio

I = Iron overload increases risk

B = Bullae

R = Raw oysters

I = Invasive sepsis

O = Ocean exposure

Vibrio vulnificus Classic Triad

LIVER + OYSTER + BULLAE

Chronic liver disease

• ●

Raw oyster exposure

• ●

Hemorrhagic bullae/sepsis

→ VIBRIO VULNIFICUS

This is one of the most important Vibrio patterns to recognize clinically.

Prevention

Important preventive measures include:

• Avoiding raw or undercooked shellfish

• Thoroughly cooking oysters, clams, and mussels

• Preventing seawater exposure of open wounds

• Covering wounds when marine exposure is unavoidable

• Using protective footwear and gloves when handling seafood

• Promptly cleaning wounds exposed to seawater

Patients with:

Chronic liver disease or iron overload

should be particularly cautious about eating:

Raw oysters

because of their increased risk of severe V. vulnificus infection.

High-Yield Clinical Pattern – Gastroenteritis

Raw seafood

• ●

Incubation around 24 hours

• ●

Acute watery diarrhea

→ Think VIBRIO, especially V. parahaemolyticus

High-Yield Clinical Pattern – Sepsis

Cirrhosis or iron overload

• ●

Raw oysters

• ●

Septic shock

• ●

Hemorrhagic bullae

→ Think VIBRIO VULNIFICUS

High-Yield Clinical Pattern – Wound Infection

Open wound

• ●

Seawater exposure

• ●

Rapidly progressive cellulitis

• ●

Bullae and tissue necrosis

→ Think VIBRIO VULNIFICUS

Exam Essentials

Genus: Vibrio

Organism: Curved Gram-negative bacillus

Oxidase: Positive

Environment: Seawater and brackish water

Major exposure: Raw seafood, especially oysters

Enteritis incubation: Approximately 24 hours, range 5–92 hours in the source

Major syndromes: Gastroenteritis, wound infection, bacteremia/sepsis

Classic gastroenteritis species: V. parahaemolyticus

Most dangerous invasive species: V. vulnificus

Major V. vulnificus risk factor: Chronic liver disease

Other major risk: Iron overload/hemochromatosis

Classic severe skin finding: Hemorrhagic bullae

Diagnosis: Culture

Selective medium: TCBS agar

Gastroenteritis management: Fluid and electrolyte replacement

Source antimicrobial: Doxycycline

Severe wound infection: Urgent antibiotics + surgical evaluation/debridement

Prevention: Cook shellfish and protect open wounds from seawater

Final Memory Aid

VIBRIO VULNIFICUS = VULNERABLE LIVER

Think:

VULNERABLE liver

• ●

OYSTERS

• ●

OCEAN

• ●

BULLAE

• ●

SEPSIS

→ V. VULNIFICUS

Key clinical pearl: Vibrio species are curved, oxidase-positive Gram-negative bacilli associated with seawater and raw seafood. V. parahaemolyticus classically causes seafood-associated gastroenteritis, whereas V. vulnificus can cause rapidly fatal septicemia or necrotizing wound infection. The combination of chronic liver disease or iron overload, raw oyster consumption, septic shock, and hemorrhagic bullae is a classic clue to V. vulnificus.

Infectious Disease and Microbiology – Veillonella parvula

Overview

Veillonella parvula is an anaerobic Gram-negative coccus that forms part of the normal human microbiota, particularly the oropharyngeal cavity. Although usually a harmless commensal, it can act as an opportunistic pathogen, particularly as part of polymicrobial infections involving the mouth and female genital tract.

Because Veillonella normally colonizes mucosal surfaces, its recovery from a clinical specimen must be interpreted according to the site of isolation and clinical context.

Classification

Genus: Veillonella

Species: Veillonella parvula

Organism: Anaerobic Gram-negative coccus

Microbiologic Characteristics

V. parvula is:

• Gram-negative

• Coccal in morphology

• Obligately anaerobic

• Non-spore-forming

• Part of the normal human mucosal flora

• Relatively slow-growing under laboratory conditions

Its Gram-negative coccal morphology is particularly notable because most clinically familiar anaerobic cocci are Gram-positive.

High-Yield Microbiology Pattern

Gram-negative coccus

• ●

Anaerobic

• ●

Normal oral flora

• ●

Polymicrobial infection

→ Think VEILLONELLA

Incubation Period

The incubation period is:

Unknown

Because V. parvula usually causes opportunistic endogenous infection rather than a classic newly acquired communicable illness, a specific incubation period is generally not clinically useful.

Epidemiology

Veillonella species have a:

Worldwide distribution

They are normal inhabitants of human mucosal surfaces, particularly the:

Oropharynx and oral cavity

Normal Flora

V. parvula can exist as part of the normal:

• Oral flora

• Oropharyngeal flora

• Gastrointestinal microbiota

• Genitourinary microbiota

Therefore:

ISOLATION DOES NOT ALWAYS EQUAL INFECTION

Its clinical importance depends on the specimen source and evidence of infection.

Pathogenesis

Most infections are:

Endogenous

This means that organisms from the patient’s normal flora gain access to tissues where they do not normally belong.

This may occur following:

• Mucosal disruption

• Dental disease

• Tissue injury

• Surgery or instrumentation

• Polymicrobial infection

Oral Infections

The source identifies V. parvula as a probable contributor to:

ORAL INFECTIONS

Because it is a normal component of oral microbial communities, it may participate in polymicrobial processes involving:

• Dental plaque

• Periodontal disease

• Dental infections

• Oral abscesses

High-Yield Oral Pattern

Anaerobic polymicrobial oral infection

• ●

Gram-negative cocci

• ●

Normal oropharyngeal flora

→ Consider Veillonella parvula

Female Genital Tract Infection

The source notes that V. parvula may contribute to:

Mixed infections of the female genital tract

These infections are usually:

Polymicrobial

rather than caused by Veillonella alone.

Opportunistic Infection

Although uncommon, Veillonella species can occasionally be recovered from deeper or normally sterile sites.

The significance is greater when the organism is:

Repeatedly isolated from a normally sterile specimen

and the patient has a compatible clinical syndrome.

Diagnosis

The primary diagnostic method is:

ANAEROBIC CULTURE

Because V. parvula is anaerobic, specimens must be:

Collected and transported appropriately for anaerobic culture

Prolonged Incubation

An important laboratory characteristic from the source is:

SLOW GROWTH

Culture may require:

Prolonged incubation

before V. parvula becomes detectable.

High-Yield Diagnostic Pattern

Anaerobic Gram-negative coccus

• ●

Slow/prolonged culture growth

• ●

Oral or polymicrobial infection

→ Think V. PARVULA

Specimen Collection

When anaerobic infection is suspected, the best specimens generally come from:

Deep tissue, aspirated material, or normally sterile sites

rather than superficial swabs.

This helps distinguish:

True infection

from

Normal mucosal colonization

Treatment

The source identifies:

CLINDAMYCIN

as the primary treatment.

Additional Treatment

The source also lists:

• Penicillin G

• Metronidazole

as additional antimicrobial options.

For clinically significant invasive disease, therapy should ideally be based on:

Antimicrobial susceptibility + infection site + polymicrobial context

Polymicrobial Infection

Because Veillonella commonly participates in:

Mixed anaerobic infections

treatment may need to cover other organisms present in the same infection.

Management therefore depends on the:

Entire microbial syndrome

rather than Veillonella alone.

Source Control

When Veillonella is involved in an abscess or other localized deep infection, antimicrobial therapy may need to be combined with:

Drainage or other appropriate source control

Veillonella vs. Neisseria

Both are:

Gram-negative cocci

but their oxygen requirements are very different.

Veillonella

→ Anaerobic

→ Normal oral flora

→ Usually opportunistic/polymicrobial

Neisseria

→ Aerobic/facultative capnophilic organisms

→ N. gonorrhoeae → gonorrhea

→ N. meningitidis → meningitis/meningococcemia

High-Yield Distinction

Gram-negative cocci + anaerobic

→ VEILLONELLA

Gram-negative diplococci + gonorrhea/meningitis

→ NEISSERIA

Veillonella vs. Peptostreptococcus

Both may participate in:

Anaerobic polymicrobial infections

However:

Veillonella

→ Gram-negative cocci

Peptostreptococcus

→ Gram-positive anaerobic cocci

This Gram-stain distinction is useful for examinations.

Veillonella vs. Porphyromonas

Both may occur in:

Anaerobic oral infections

Veillonella

→ Gram-negative coccus

Porphyromonas

→ Gram-negative bacillus

→ Strong association with periodontal disease

High-Yield Clinical Pattern

Oral/dental infection

• ●

Polymicrobial anaerobic flora

• ●

Gram-negative coccus

• ●

Prolonged anaerobic culture

→ Think VEILLONELLA PARVULA

Exam Essentials

Genus: Veillonella

Species: V. parvula

Organism: Anaerobic Gram-negative coccus

Incubation: Unknown

Distribution: Worldwide

Normal habitat: Oropharyngeal/oral flora

Pathogenesis: Usually endogenous and opportunistic

Major infection association: Oral infections

Other association: Mixed infections of the female genital tract

Typical infection type: Frequently polymicrobial

Diagnosis: Anaerobic culture

Culture characteristic: May require prolonged incubation

Source treatment: Clindamycin

Additional source treatments: Penicillin G or metronidazole

Important interpretation: Distinguish normal colonization from true infection

Memory Aid

VEILLONELLA = VERY ANAEROBIC ORAL COCCUS

Think:

V = Veillonella

V = Very anaerobic

O = Oral flora

C = Coccus

And remember:

ANAEROBIC + GRAM-NEGATIVE + COCCUS = VEILLONELLA

Classic Exam Pattern

Normal oral flora

• ●

Anaerobic polymicrobial infection

• ●

Gram-negative cocci

• ●

Slow growth on anaerobic culture

→ Veillonella parvula

Key clinical pearl: Veillonella parvula is an anaerobic Gram-negative coccus that normally inhabits the oropharynx and may participate in polymicrobial oral and female genital tract infections. Diagnosis requires appropriate anaerobic culture and may require prolonged incubation. Because it is normal mucosal flora, its isolation must always be interpreted in clinical context to distinguish colonization from true infection.

Infectious Disease and Microbiology – Ureaplasma urealyticum and Ureaplasma parvum

Overview

Ureaplasma urealyticum and Ureaplasma parvum are extremely small bacteria belonging to the group of organisms that lack a cell wall. They commonly colonize the human genitourinary tract and may be associated with nongonococcal urethritis, pregnancy-related infections such as chorioamnionitis, and invasive infection in newborns.

Because Ureaplasma lacks a cell wall, antibiotics that act on bacterial cell-wall synthesis, such as penicillins and cephalosporins, are intrinsically ineffective.

Classification

Genus: Ureaplasma

Important species:

• Ureaplasma urealyticum

• Ureaplasma parvum

Organism: Very small bacterium without a cell wall

Microbiologic Characteristics

Ureaplasma organisms are:

• Extremely small

• Cell-wall deficient

• Pleomorphic

• Poorly visualized by routine Gram staining

• Capable of colonizing the genitourinary tract

• Dependent on specialized culture conditions

They are closely related to:

Mycoplasma

No Cell Wall

The single most important microbiologic feature is:

UREAPLASMA HAS NO CELL WALL

Therefore, it lacks the usual:

Peptidoglycan layer

found in most bacteria.

Antibiotic Consequence

Because there is no cell wall:

β-lactam antibiotics have no target.

Therefore:

• Penicillin → ineffective

• Amoxicillin → ineffective

• Cephalosporins → ineffective

• Carbapenems → ineffective

This is an important examination point.

High-Yield Microbiology Pattern

Very small bacterium

• ●

No cell wall

• ●

Genitourinary tract

• ●

Urethritis

→ Think UREAPLASMA

Urease Activity

The name Ureaplasma reflects an important metabolic characteristic:

UREA HYDROLYSIS

These organisms possess:

Urease

and use urea as an important metabolic substrate.

This feature helps distinguish Ureaplasma from many Mycoplasma species.

Memory Aid

UREA-plasma → UREA → UREASE

Incubation Period

For sexually acquired nongonococcal urethritis associated with U. urealyticum, the source gives an incubation period of approximately:

10–20 DAYS

Epidemiology

Ureaplasma species occur:

Worldwide

They frequently colonize the:

Lower genitourinary tract

without producing symptoms.

Therefore, detection of Ureaplasma does not always mean that it is responsible for a patient’s disease.

Colonization vs. Infection

This distinction is particularly important.

Ureaplasma may be present in healthy individuals as:

Asymptomatic colonizing flora

Therefore:

Positive test ≠ automatically active infection

Clinical findings and the site of detection must be considered when determining whether the organism is clinically significant.

Transmission

Transmission can occur through:

Sexual contact

and from mother to infant through:

Vertical/perinatal transmission

Maternal genital colonization can therefore be important in pregnancy and neonatal disease.

Nongonococcal Urethritis

One of the infections associated with U. urealyticum is:

NONGONOCOCCAL URETHRITIS (NGU)

Possible manifestations include:

• Dysuria

• Urethral discomfort

• Urethral discharge

• Urethral irritation

However, other organisms—particularly Chlamydia trachomatis and Mycoplasma genitalium—are also important causes of NGU.

High-Yield Clinical Pattern

Sexual exposure

• ●

10–20 days

• ●

Urethritis

• ●

No gonococcal infection identified

→ Consider Ureaplasma urealyticum

Pregnancy-Associated Infection

Ureaplasma species may be associated with infections involving:

Pregnancy and the fetal membranes

The source specifically identifies:

CHORIOAMNIONITIS

Chorioamnionitis

Chorioamnionitis is infection and inflammation involving the:

Chorion and amnion

Ureaplasma can ascend from the maternal genital tract and may participate in:

Intra-amniotic infection and inflammation

Neonatal Infection

The source also identifies:

DISSEMINATED INFECTION IN THE NEWBORN

Neonates, particularly premature infants, may be vulnerable to invasive infection because of:

Immature host defenses

Other Neonatal Associations

Depending on the clinical setting, Ureaplasma has also been associated with:

• Respiratory tract colonization/infection

• Pneumonia

• Bacteremia

• Meningitis

Premature infants represent an especially important susceptible population.

High-Yield Neonatal Pattern

Maternal genital colonization/infection

↓

Ascending or perinatal exposure

↓

Premature/newborn infant

↓

Respiratory or disseminated infection

→ Consider Ureaplasma

Diagnosis

The source lists:

• Culture on special media

• Serologic testing

• PCR

Special Culture Requirements

Routine bacterial culture may fail to detect Ureaplasma.

The organism requires:

SPECIALIZED CULTURE MEDIA

Because it hydrolyzes urea, appropriate specialized media can help identify its characteristic metabolic activity.

Gram Stain

Routine Gram staining is not particularly useful because:

THERE IS NO CELL WALL

Therefore, the organism does not produce the conventional Gram-staining appearance expected from typical bacteria.

PCR

Molecular testing using:

PCR/NAAT

can detect Ureaplasma nucleic acid and may be particularly useful when routine cultures are negative or specialized culture is unavailable.

Interpretation still requires clinical context because:

Colonization is common.

Treatment

The source recommends:

MACROLIDE ANTIBIOTIC

for approximately:

7–14 days

depending on the clinical syndrome.

Additional Treatment

The source lists:

• Doxycycline

• Ofloxacin

as additional treatment options.

Antimicrobial selection should account for:

Patient population, infection site, pregnancy status, local resistance, and susceptibility when available.

Ciprofloxacin Resistance

The source specifically warns against:

CIPROFLOXACIN

because a substantial proportion of U. urealyticum isolates may be resistant.

Resistance patterns vary geographically and over time, so susceptibility and current clinical guidance are important for serious infections.

β-Lactam Resistance

Unlike acquired resistance, resistance to β-lactams is a direct consequence of the organism’s biology.

Because Ureaplasma has:

NO CELL WALL

it is intrinsically resistant to drugs targeting:

Peptidoglycan synthesis

High-Yield Treatment Rule

NO WALL = NO β-LACTAMS

Think:

Penicillin ✗

Cephalosporin ✗

Macrolide ✓

Doxycycline ✓

Ureaplasma vs. Mycoplasma

Both organisms:

• Are extremely small

• Lack cell walls

• Are pleomorphic

• Do not respond to β-lactams

• Require specialized diagnostic approaches

However:

Ureaplasma

→ Hydrolyzes urea

→ Strong genitourinary association

→ Urethritis

→ Chorioamnionitis

→ Neonatal disease

Mycoplasma pneumoniae

→ Primarily respiratory

→ Atypical “walking” pneumonia

→ May be associated with cold agglutinins

Ureaplasma vs. Mycoplasma genitalium

Both may be associated with:

Nongonococcal urethritis

Ureaplasma urealyticum

→ Frequently colonizes GU tract

→ Pathogenic significance may depend on clinical context and organism burden

Mycoplasma genitalium

→ Established sexually transmitted cause of persistent/recurrent NGU

→ Also associated with cervicitis and PID

→ Antimicrobial resistance is a major treatment issue

Ureaplasma vs. Chlamydia trachomatis

Both can be associated with:

Nongonococcal urethritis

Ureaplasma

→ No cell wall

→ Urease positive

→ β-lactams ineffective

→ Specialized culture/PCR

Chlamydia trachomatis

→ Obligate intracellular organism

→ Elementary and reticulate body life cycle

→ Major established cause of NGU and cervicitis

High-Yield Clinical Pattern

Nongonococcal urethritis

• ●

Very small pleomorphic bacterium

• ●

No cell wall

• ●

Urea hydrolysis

• ●

β-lactam resistance

→ Think UREAPLASMA UREALYTICUM

High-Yield Pregnancy Pattern

Genital colonization

• ●

Pregnancy

• ●

Chorioamnionitis

• ●

Premature or infected newborn

→ Consider UREAPLASMA

Exam Essentials

Genus: Ureaplasma

Species: U. urealyticum and U. parvum

Organism: Very small bacterium

Cell wall: Absent

Gram stain: Poorly visualized/not conventionally Gram stained

Important metabolic feature: Urease activity

Distribution: Worldwide

Colonization: Common in the genitourinary tract

NGU incubation in source: 10–20 days

Major adult infection: Nongonococcal urethritis

Pregnancy association: Chorioamnionitis

Neonatal disease: Respiratory and potentially disseminated infection

Diagnosis: Special culture media + molecular testing/PCR

Source treatment: Macrolide for 7–14 days

Additional source treatment: Doxycycline or ofloxacin

Important resistance concept: β-lactams are intrinsically ineffective because there is no cell wall

Ciprofloxacin: Source notes substantial resistance

Memory Aid

UREAPLASMA = UREA + NO WALL

Think:

UREA

→ Urease

PLASMA

→ Tiny cell-wall-deficient organism

And remember:

NO WALL → NO PENICILLIN

Classic Exam Pattern

Sexually active patient

• ●

Nongonococcal urethritis

• ●

Organism lacks cell wall

• ●

Urease positive

→ Ureaplasma urealyticum

Key clinical pearl: Ureaplasma urealyticum and U. parvum are very small, cell-wall-deficient bacteria that commonly colonize the genitourinary tract. They are associated with nongonococcal urethritis, chorioamnionitis, and neonatal infection. Their absence of a peptidoglycan cell wall makes β-lactam antibiotics intrinsically ineffective, while their ability to hydrolyze urea is a characteristic microbiologic clue.

Infectious Disease and Microbiology – Tunga penetrans

Overview

Tunga penetrans is a hematophagous flea that causes tungiasis, a parasitic skin infestation produced when the fertilized female flea penetrates and embeds within the skin.

The infection most commonly affects the feet, where it produces painful inflammatory nodules that can sometimes resemble myiasis.

Classification

Genus: Tunga

Species: Tunga penetrans

Organism: Hematophagous flea (arthropod ectoparasite)

Disease: Tungiasis

Microbiologic Characteristics

T. penetrans is a very small flea that feeds on blood.

The clinically important event is:

Penetration of the skin by the gravid female flea

After entering the skin, the flea enlarges as it feeds and develops eggs.

High-Yield Microbiology Pattern

Flea

• ●

Skin penetration

• ●

Painful nodule on the foot

• ●

Endemic tropical region

→ Think TUNGA PENETRANS

Incubation Period

The incubation period is:

Unknown

Symptoms develop after the female flea penetrates and enlarges within the skin.

Epidemiology

T. penetrans is most commonly encountered in:

• Sub-Saharan Africa

• Central America

• South America

• Tropical and subtropical regions of Asia and other endemic areas

The infection is particularly associated with:

Poor housing conditions, sandy soil, and frequent barefoot exposure

Environmental Exposure

The flea may be encountered in:

• Dry sandy soil

• Dirt floors

• Animal resting areas

• Areas where humans and domestic animals live in close contact

Walking barefoot increases the risk of infestation.

Transmission

Tungiasis occurs when:

A fertilized female flea penetrates exposed skin

The usual site is the:

Foot

especially around:

• Toes

• Nail folds

• Soles

• Heels

Pathogenesis

After penetrating the skin:

Female flea enters epidermis

↓

The posterior end remains connected with the exterior

↓

The flea feeds on blood and enlarges

↓

Eggs develop within the flea

↓

Inflammatory reaction develops around the embedded parasite

↓

Painful or pruritic nodule forms

Tungiasis

The disease caused by T. penetrans is called:

TUNGIASIS

Typical lesions are:

Painful inflammatory nodules

most commonly located on the feet.

Typical Lesion

A classic lesion may appear as:

A whitish or yellowish papule or nodule with a central dark punctum

The central dark point corresponds to the portion of the embedded flea that remains open to the environment.

High-Yield Lesion Pattern

Painful foot nodule

• ●

Central black dot/punctum

• ●

Barefoot exposure in endemic region

→ Think TUNGA PENETRANS

Clinical Manifestations

Patients may experience:

• Local pain

• Pruritus

• Swelling

• Erythema

• Tenderness

• Difficulty walking if lesions are numerous

Multiple infestations may produce substantial inflammation and disability.

Common Sites

The feet are most commonly involved, particularly:

• Periungual skin

• Interdigital spaces

• Soles

• Heels

• Toes

Other exposed skin sites can occasionally be affected.

Complications

Secondary bacterial infection can develop because the skin barrier is disrupted.

Possible complications include:

• Cellulitis

• Abscess formation

• Ulceration

• Lymphangitis

• Tissue necrosis in severe disease

Heavy infestation may also lead to:

Difficulty walking and chronic inflammation

Tetanus Risk

Because tungiasis creates an open skin lesion, attention should be given to:

Tetanus immunization status

particularly when lesions are contaminated or surgically manipulated.

Diagnosis

Diagnosis is usually made by:

IDENTIFICATION OF THE FLEA WITHIN THE LESION

The source specifically emphasizes:

Finding and examining the flea in the skin lesion

Clinical Diagnosis

In endemic settings, the diagnosis may be strongly suggested by:

Characteristic foot lesions with a central punctum

combined with:

Appropriate environmental exposure

Differential Diagnosis

Tungiasis can be confused with:

• Myiasis

• Plantar wart

• Foreign body granuloma

• Bacterial abscess

• Furuncle

• Other arthropod infestations

Tungiasis vs. Myiasis

This is an important distinction.

Tungiasis

→ Caused by a flea

→ Organism: Tunga penetrans

→ Female flea penetrates skin

→ Usually affects feet

→ Central dark punctum may be visible

Myiasis

→ Caused by fly larvae

→ Larva develops within skin or tissue

→ Furuncular lesion may contain a breathing pore

→ Movement may sometimes be felt

High-Yield Distinction

Embedded flea + foot nodule

→ TUNGIASIS

Embedded fly larva + furuncular lesion

→ MYIASIS

Treatment

The traditional treatment described in the source is:

SURGICAL EXCISION

The embedded flea and affected tissue are carefully removed.

Important Treatment Principle

Removal should be performed:

Carefully and under clean/sterile conditions

to reduce the risk of:

• Retained parasite material

• Tissue injury

• Secondary bacterial infection

Topical Antibiotics

The source notes that:

Topical antibiotics

may be required when there is evidence of:

Localized secondary bacterial infection

Oral Antibiotics

If significant bacterial superinfection develops after removal, the source notes that:

Oral antibiotics

may be required.

These should be directed toward the suspected bacterial infection rather than the flea itself.

Supportive Care

Additional management may include:

• Cleansing of the affected area

• Wound care

• Pain control

• Evaluation for bacterial infection

• Checking tetanus immunization status

Prevention

Prevention focuses on avoiding contact with infested soil.

Useful measures include:

• Wearing closed footwear

• Avoiding walking barefoot in endemic areas

• Improving flooring in homes

• Controlling flea infestation in domestic animals

• Environmental sanitation

• Regular inspection of feet in high-risk populations

Tunga penetrans vs. Cutaneous Larva Migrans

Tunga penetrans

→ Flea embedded in skin

→ Localized painful nodule

→ Frequently feet

→ Central punctum

Cutaneous larva migrans

→ Usually dog/cat hookworm larvae

→ Serpiginous, migrating track

→ Intensely pruritic

→ Larva migrates within superficial skin

Tunga penetrans vs. Scabies

Tungiasis

→ Localized embedded flea

→ Often foot lesion

→ Visible central punctum

Scabies

→ Sarcoptes scabiei

→ Multiple intensely pruritic lesions

→ Burrows

→ Commonly fingers, wrists, waist, genital region

→ No embedded flea nodule

High-Yield Clinical Pattern

Traveler or resident of tropical endemic region

• ●

Barefoot exposure

• ●

Painful foot nodule

• ●

Central black punctum

• ●

Embedded flea identified

→ Think TUNGA PENETRANS

Exam Essentials

Genus: Tunga

Species: T. penetrans

Organism: Hematophagous flea

Disease: Tungiasis

Incubation: Unknown

Distribution: Mainly tropical and subtropical regions of Africa, Central and South America, and parts of Asia

Transmission: Mature female flea penetrates the skin

Most common site: Feet

Typical lesion: Painful inflammatory nodule, often with a central dark punctum

Major differential: Myiasis

Diagnosis: Identification/examination of the flea within the lesion

Treatment: Careful removal or excision of the embedded flea

Secondary infection: Topical or oral antibiotics when clinically indicated

Prevention: Footwear, sanitation, environmental flea control, and avoidance of infested soil

Memory Aid

TUNGA = TOE FLEA

Think:

Tropical area

• ●

Barefoot

• ●

Toe/foot

• ●

Tiny black central punctum

→ Tunga penetrans

And:

FLEA IN FOOT = TUNGIASIS

Key clinical pearl: Tunga penetrans is a blood-feeding flea that causes tungiasis when the gravid female penetrates the skin, usually of the feet. The classic lesion is a painful nodule with a central dark punctum in a person with barefoot exposure in an endemic region. Diagnosis is made by identifying the embedded flea, and treatment centers on careful removal with management of any secondary bacterial infection.

Infectious Disease and Microbiology – Tropheryma whipplei

Overview

Tropheryma whipplei is a Gram-positive, intracellular bacterium responsible for Whipple disease, a rare chronic multisystem infection. The disease classically affects the small intestine, producing diarrhea and malabsorption, but it can also involve the joints, central nervous system, heart, lymph nodes, and other organs.

A particularly important clinical sequence is migratory arthralgia that precedes gastrointestinal symptoms, sometimes by years.

Classification

Genus: Tropheryma

Species: Tropheryma whipplei

Organism: Gram-positive intracellular bacillus

Disease: Whipple disease

The older spelling:

Tropheryma whippelii

has largely been replaced by:

Tropheryma whipplei

Microbiologic Characteristics

T. whipplei is:

• A Gram-positive bacterium

• Intracellular

• Difficult to identify by routine culture

• Associated with chronic infection of macrophages

• Capable of producing multisystem disease

The organism accumulates within macrophages, particularly in the:

Small-intestinal lamina propria

High-Yield Microbiology Pattern

Intracellular Gram-positive bacterium

• ●

PAS-positive macrophages in small intestine

• ●

Migratory arthralgia

• ●

Diarrhea and malabsorption

→ Think TROPHERYMA WHIPPLEI

Incubation Period

The incubation period is:

Unknown

Whipple disease typically follows a:

Chronic, slowly progressive course

rather than a clearly defined acute incubation period.

Epidemiology

T. whipplei probably has a:

Worldwide distribution

Exposure or asymptomatic carriage appears to be more common than clinically apparent Whipple disease.

Actual disease is:

Rare

suggesting that host susceptibility contributes substantially to disease development.

Whipple Disease

The major clinical syndrome is:

WHIPPLE DISEASE

It is a chronic:

Multisystem infectious disease

that classically combines:

Joint symptoms + gastrointestinal disease + systemic manifestations

Classic Clinical Sequence

One of the most characteristic patterns is:

Migratory arthralgia

↓

Months or years later

↓

Diarrhea

• ●

Malabsorption

• ●

Weight loss

This sequence is highly characteristic of:

T. whipplei

Migratory Arthralgia

Joint manifestations are often among the:

Earliest symptoms

Patients may experience:

• Migratory arthralgia

• Intermittent arthritis

• Pain involving multiple joints

Importantly, joint symptoms can precede gastrointestinal disease by:

Several years

High-Yield Early Clue

Recurrent migratory arthralgia for years

↓

Later develops:

Chronic diarrhea + weight loss + malabsorption

→ Think WHIPPLE DISEASE

Gastrointestinal Disease

The small intestine is a major site of infection.

Typical manifestations include:

• Chronic diarrhea

• Steatorrhea

• Abdominal discomfort

• Weight loss

• Malabsorption

Malabsorption

Accumulation of infected macrophages within the intestinal mucosa interferes with:

Normal nutrient absorption

This can result in:

• Weight loss

• Nutritional deficiencies

• Weakness

• Hypoalbuminemia

• Anemia in some patients

Lymphadenopathy

The source identifies:

LYMPHADENOPATHY

as another important manifestation.

Mesenteric and peripheral lymph nodes may become involved as part of the systemic infection.

Fever

Patients may experience:

Intermittent or persistent fever

along with other constitutional symptoms such as:

• Fatigue

• Malaise

• Weight loss

Neurologic Whipple Disease

The central nervous system may be involved.

Possible manifestations include:

• Cognitive changes

• Confusion

• Memory impairment

• Ataxia

• Abnormal eye movements

• Seizures

• Hypothalamic dysfunction

• Other focal or diffuse neurologic abnormalities

Oculomasticatory Myorhythmia

A particularly distinctive neurologic manifestation is:

OCULOMASTICATORY MYORHYTHMIA

This consists of rhythmic movements involving the:

Eyes and masticatory muscles

Although uncommon, it is considered highly suggestive of:

CNS Whipple disease

Cardiac Disease

T. whipplei can also cause:

Endocarditis

An important pattern is:

Blood culture-negative endocarditis

because the organism is difficult to recover using conventional bacterial culture techniques.

High-Yield Cardiac Pattern

Endocarditis

• ●

Repeatedly negative routine blood cultures

• ●

Arthralgia/systemic features

→ Consider T. whipplei

Diagnosis

The source identifies two major diagnostic approaches:

• Histologic examination of intestinal biopsy or lymph node

• PCR

Small-Bowel Biopsy

A classic diagnostic procedure is:

Upper endoscopy with small-intestinal biopsy

particularly from the:

Duodenum or proximal small bowel

PAS-Positive Macrophages

The classic histologic finding is:

PAS-POSITIVE FOAMY MACROPHAGES

within the:

Lamina propria of the small intestine

PAS stands for:

Periodic acid–Schiff

The macrophages contain bacterial material from T. whipplei.

Classic Pathology Pattern

Small-intestinal biopsy

↓

Lamina propria filled with foamy macrophages

↓

PAS-positive intracellular material

→ Think WHIPPLE DISEASE

PCR

Polymerase chain reaction (PCR) can detect T. whipplei DNA.

Depending on the clinical syndrome, testing may involve:

• Intestinal tissue

• Lymph-node tissue

• Cerebrospinal fluid

• Synovial fluid

• Cardiac tissue

• Other appropriate specimens

PCR is particularly useful for:

Confirming the organism in compatible clinical disease

Diagnostic Caution

Detection of T. whipplei DNA at some nonsterile sites does not automatically prove:

Whipple disease

because asymptomatic carriage can occur.

Diagnosis therefore requires correlation between:

Clinical syndrome + histopathology + appropriate molecular testing

Treatment

The source lists:

TRIMETHOPRIM–SULFAMETHOXAZOLE (TMP-SMX)

as the primary treatment.

Whipple disease requires:

Prolonged antimicrobial therapy

because of its systemic nature and potential involvement of sanctuary sites such as the CNS.

Additional Treatment

The source lists:

• Penicillin V

• Chloramphenicol

• Tetracycline

as additional treatment options.

These reflect historical therapeutic approaches.

For modern management, treatment selection needs to consider:

CNS penetration, disease location, relapse risk, and antimicrobial susceptibility/clinical guidance.

CNS Considerations

Even patients without obvious neurologic symptoms may have clinically important concern for:

CNS involvement

Therefore, antimicrobial regimens for classic Whipple disease are generally selected with adequate:

Central nervous system penetration

in mind.

Relapse

Whipple disease can:

Relapse

including after apparently successful therapy.

Relapses may involve the:

Central nervous system

and can occur after gastrointestinal symptoms have improved.

Long-term clinical follow-up is therefore important.

Whipple Disease vs. Celiac Disease

Both may cause:

Diarrhea + malabsorption + weight loss

but:

Whipple Disease

→ T. whipplei infection

→ Migratory arthralgia often precedes GI disease

→ PAS-positive macrophages

→ Lymphadenopathy/fever possible

→ Neurologic or cardiac involvement possible

Celiac Disease

→ Immune-mediated response to gluten

→ Villous atrophy

→ Characteristic celiac serology

→ No intracellular bacterial infection

Whipple Disease vs. Mycobacterium avium Complex

Both can produce macrophage-rich intestinal disease, particularly in the appropriate clinical setting.

Whipple Disease

→ PAS-positive macrophages

→ T. whipplei PCR

→ Migratory arthralgia + malabsorption

→ Acid-fast staining generally negative

Disseminated MAC

→ Acid-fast bacilli within macrophages

→ Particularly associated with advanced cellular immunodeficiency

High-Yield Distinction

PAS-positive + acid-fast negative macrophages

→ Think T. whipplei

Macrophages packed with acid-fast bacilli

→ Think MAC

Whipple Disease vs. Tropical Sprue

Both can cause:

Chronic diarrhea and malabsorption

However:

Whipple Disease

→ Migratory arthralgia

→ PAS-positive macrophages

→ Multisystem disease

→ Neurologic/cardiac involvement

Tropical Sprue

→ Malabsorptive syndrome associated with tropical residence

→ No characteristic PAS-positive macrophages containing T. whipplei

High-Yield Clinical Pattern

Years of migratory arthralgia

• ●

Chronic diarrhea

• ●

Weight loss and malabsorption

• ●

Lymphadenopathy

• ●

PAS-positive foamy macrophages in small-bowel biopsy

→ Think TROPHERYMA WHIPPLEI

High-Yield Extraintestinal Pattern

Culture-negative endocarditis

or

Unexplained neurologic disease

• ●

History of migratory arthralgia

±

GI malabsorption

→ Consider Whipple disease

Exam Essentials

Genus: Tropheryma

Species: T. whipplei

Older spelling: T. whippelii

Organism: Intracellular Gram-positive bacterium

Disease: Whipple disease

Distribution: Probably worldwide

Incubation: Unknown

Classic early manifestation: Migratory arthralgia

Classic GI manifestations: Diarrhea + malabsorption + weight loss

Other manifestations: Fever and lymphadenopathy

Neurologic disease: May occur

Cardiac manifestation: Culture-negative endocarditis

Classic biopsy: PAS-positive foamy macrophages in small-intestinal lamina propria

Molecular diagnosis: PCR

Primary source treatment: TMP-SMX

Other source treatments: Penicillin V, chloramphenicol, tetracycline

Important management issue: Prolonged therapy and attention to CNS disease/relapse

Memory Aid

WHIPPLE = WEIGHT LOSS + HIPS HURT + INTESTINE

Think:

Migratory joint pain

↓

Diarrhea

↓

Malabsorption

↓

Weight loss

↓

PAS-positive macrophages

→ Tropheryma whipplei

Another classic association:

WHIPPLE = PAS-POSITIVE MACROPHAGES

Key clinical pearl: Tropheryma whipplei causes Whipple disease, a chronic multisystem infection classically characterized by migratory arthralgia that may precede diarrhea, weight loss, and malabsorption by years. The classic diagnostic finding is PAS-positive foamy macrophages in the small-intestinal lamina propria, with PCR providing organism-specific confirmation. Neurologic disease and culture-negative endocarditis are important extraintestinal manifestations, and prolonged antimicrobial therapy is required because relapse, particularly involving the CNS, can occur.

Medicine – Motor Neurone Disease (Amyotrophic Lateral Sclerosis)

Motor neurone disease (MND) is a progressive neurodegenerative disorder affecting motor neurones. The term amyotrophic lateral sclerosis (ALS) is often used for the common form in which both upper motor neurones and lower motor neurones are involved.

Although the original note emphasizes anterior horn cells, ALS affects more than just the spinal anterior horn. It also involves corticospinal pathways and motor nuclei in the brainstem, which explains the mixture of UMN, LMN, bulbar, and respiratory features.

1. Main Pathology

The disease causes progressive degeneration of:

Upper motor neurones in the motor cortex and corticospinal tracts.

Lower motor neurones in the anterior horn cells of the spinal cord.

Motor cranial nerve nuclei in the brainstem.

This creates the characteristic combination of:

UMN signs + LMN signs in the same patient.

2. Upper Motor Neurone Signs

Upper motor neurone involvement may cause:

Increased tone or spasticity.

Brisk reflexes.

Clonus.

Extensor plantar responses.

Spastic dysarthria when corticobulbar pathways are involved.

These signs reflect degeneration of descending motor pathways.

3. Lower Motor Neurone Signs

Lower motor neurone involvement produces:

Muscle weakness.

Muscle wasting.

Fasciculations.

Reduced tone in affected muscles.

Reduced reflexes where LMN involvement is severe.

The combination of wasting and fasciculation with brisk reflexes elsewhere is particularly suggestive of MND.

4. Limb Weakness

Weakness is progressive and may begin focally.

The upper limbs are commonly affected, and weakness may be particularly noticeable in the hands.

Patients may report difficulty with:

Buttons.

Writing.

Turning keys.

Opening jars.

Using cutlery.

Progression may then involve other limbs.

5. Hand Wasting

Wasting of the intrinsic hand muscles can be an early and striking feature.

The patient may develop:

Interosseous muscle wasting.

Thenar or hypothenar wasting.

Weak grip.

Loss of fine finger movements.

This reflects lower motor neurone degeneration.

6. Fasciculations

Fasciculations are visible spontaneous contractions of individual motor units.

They may appear as brief twitching under the skin.

Fasciculations are common in MND but are not specific on their own, because benign fasciculations can also occur.

Their significance is much greater when accompanied by:

Progressive weakness + muscle wasting + other UMN or LMN signs.

7. Foot Drop

Weakness of ankle dorsiflexion can produce foot drop.

The patient may develop:

High-stepping gait.

Toe catching.

Frequent tripping.

Foot drop may be an early manifestation when lower motor neurone weakness begins in the distal leg.

8. Bulbar Symptoms

Bulbar involvement occurs when motor neurones controlling speech and swallowing are affected.

Patients may develop:

Dysarthria.

Dysphagia.

Weak cough.

Choking episodes.

Aspiration.

Both bulbar palsy and pseudobulbar palsy features may occur because both LMN and UMN pathways can be involved.

9. Bulbar Palsy Features

Bulbar palsy reflects lower motor neurone involvement of the cranial nerve nuclei or their peripheral fibres.

Typical findings include:

Weak, nasal, or slurred speech.

Dysphagia.

Nasal regurgitation.

Tongue wasting.

Tongue fasciculations.

Reduced bulbar reflexes in some patients.

10. Pseudobulbar Features

Pseudobulbar palsy reflects bilateral upper motor neurone corticobulbar involvement.

Typical findings include:

Spastic or strained dysarthria.

Brisk jaw jerk.

Spastic tongue without prominent fasciculations.

Emotional lability or pseudobulbar affect.

In MND, bulbar and pseudobulbar findings may coexist.

11. Dysphagia and Aspiration

Swallowing impairment is a major clinical problem.

Patients may experience:

Coughing during meals.

Choking.

Weight loss.

Recurrent chest infections.

Aspiration pneumonia.

Progressive dysphagia may require enteral feeding support.

12. Respiratory Muscle Weakness

Respiratory failure is a major cause of morbidity and mortality in MND.

Weakness may involve:

Diaphragm.

Intercostal muscles.

Accessory respiratory muscles.

Patients may develop:

Dyspnoea.

Orthopnoea.

Morning headaches from nocturnal hypoventilation.

Poor sleep.

Daytime somnolence.

Weak cough.

13. No Sensory Signs

A classic feature of MND is the relative preservation of sensation.

Patients generally do not develop prominent:

Numbness.

Loss of vibration sense.

Loss of pain or temperature sensation.

Therefore:

Progressive motor weakness with UMN + LMN signs and no sensory loss strongly suggests MND.

Minor sensory symptoms can occur in real-world practice, but significant objective sensory loss should prompt consideration of alternative diagnoses.

14. Other Functions Often Relatively Preserved

Classically, the following are relatively preserved until late:

Sensation.

Eye movements.

Sphincter function.

However, not every patient fits a perfect textbook pattern.

Some patients can develop cognitive or behavioural changes, particularly in association with frontotemporal dementia.

15. Cognitive and Behavioural Involvement

MND is not always purely motor.

A subset of patients develop:

Executive dysfunction.

Behavioural change.

Language difficulties.

Frontotemporal dementia.

This is especially important because ALS and frontotemporal degeneration can overlap clinically and genetically.

16. Diagnosis

MND is primarily a clinical diagnosis based on progressive motor dysfunction with evidence of both UMN and LMN involvement.

The clinician looks for:

Progression over time.

Spread from one body region to another.

UMN signs.

LMN signs.

Absence of a better alternative diagnosis.

17. Electromyography

EMG is a key supportive investigation.

It can demonstrate widespread active and chronic denervation.

Typical findings may include:

Fibrillation potentials.

Positive sharp waves.

Fasciculation potentials.

Large-amplitude, long-duration motor-unit potentials from reinnervation.

EMG helps confirm LMN involvement even in muscles that may not yet appear weak clinically.

18. Nerve Conduction Studies

Nerve conduction studies are usually performed alongside EMG.

They help distinguish MND from peripheral neuropathies and other disorders.

In classic ALS:

Sensory nerve conduction is usually relatively preserved.

Motor studies may show abnormalities related to axonal loss.

Therefore, the original statement that NCS directly “reveals anterior horn cell damage” is a simplification; EMG is more directly useful for demonstrating denervation, while NCS helps exclude alternative peripheral nerve disease.

19. Other Investigations

Other investigations are mainly used to exclude mimics.

These may include:

MRI of brain and spinal cord.

Blood tests.

Thyroid function.

Vitamin B12.

Autoimmune or infectious testing where appropriate.

The exact investigation depends on the clinical presentation.

20. Important Mimics

Conditions that may resemble MND include:

Cervical myelopathy.

Peripheral neuropathy.

Multifocal motor neuropathy.

Myasthenia gravis.

Myopathies.

Vitamin B12 deficiency.

Structural spinal cord disease.

The absence of sensory loss helps, but imaging and neurophysiology are often required to exclude treatable mimics.

21. Riluzole

Riluzole is a disease-modifying treatment used in ALS.

It reduces glutamatergic neurotransmission and provides a modest survival benefit.

It does not reverse established motor neurone loss but may slow progression modestly.

22. Edaravone

In some healthcare systems and selected patients, edaravone may also be used.

It is thought to reduce oxidative cellular injury.

Eligibility and benefit vary by patient and jurisdiction, so its role is more selective than basic supportive care.

23. Muscle Relaxants

Spasticity may be treated with agents such as:

Baclofen.

Tizanidine.

Other treatments may be considered depending on severity.

The aim is to reduce painful stiffness while avoiding excessive weakness or sedation.

24. Management of Dysphagia

Progressive swallowing difficulty requires careful nutritional assessment.

Management may include:

Diet modification.

Speech and language therapy.

High-calorie nutritional support.

Enteral feeding when oral intake becomes unsafe or inadequate.

25. PEG Feeding

A percutaneous endoscopic gastrostomy, PEG, can provide nutritional support when swallowing is severely impaired.

It may help reduce:

Weight loss.

Dehydration.

Difficulty taking medication.

It does not completely eliminate aspiration risk because saliva and refluxed material can still be aspirated.

Timing is important because the procedure becomes more risky as respiratory function deteriorates.

26. Respiratory Support

The original note lists CPAP, but the more important respiratory support in MND is usually non-invasive ventilation, especially bilevel positive airway pressure.

This is because the major problem is alveolar hypoventilation from respiratory muscle weakness, rather than upper-airway collapse alone.

Therefore:

MND respiratory failure → NIV/BiPAP-type support is typically more relevant than ordinary CPAP.

27. Non-Invasive Ventilation

Non-invasive ventilation can improve:

Nocturnal hypoventilation.

Sleep quality.

Daytime symptoms.

Quality of life.

Survival in appropriately selected patients.

It is one of the most important supportive interventions in progressive respiratory muscle weakness.

28. Tracheostomy Ventilation

Some patients may choose tracheostomy with invasive ventilation.

This can provide long-term respiratory support but involves major implications for:

Communication.

Mobility.

Care requirements.

Quality of life.

Advance-care planning.

These decisions require detailed multidisciplinary discussion.

29. Secretion and Cough Management

Weak cough can lead to retained respiratory secretions.

Management may include:

Physiotherapy.

Mechanical cough-assist devices.

Suction when required.

Treatment of excessive saliva.

These measures reduce respiratory complications.

30. Communication Support

Progressive bulbar and limb weakness may impair speech and writing.

Communication aids may include:

Voice amplification.

Tablet or computer-based communication systems.

Eye-gaze technology.

Speech-generating devices.

Early planning is useful before speech deteriorates severely.

31. Multidisciplinary Team Approach

Management is best coordinated through a multidisciplinary team.

This may include:

Neurology.

Respiratory medicine.

Physiotherapy.

Occupational therapy.

Speech and language therapy.

Dietetic support.

Palliative care.

Psychological and social support.

This approach helps address the wide range of motor, nutritional, respiratory, communication, and psychosocial needs.

32. Prognosis

MND is progressive, but survival varies greatly between patients.

Older teaching sometimes gives:

Approximately 2 years for bulbar-onset disease.

Approximately 4 years for limb-onset disease.

These figures are too rigid to apply to individual patients.

In general, bulbar-onset disease tends to have a poorer prognosis than limb-onset disease, but survival ranges widely from months to many years.

33. Factors Associated with Prognosis

Prognosis depends on several factors, including:

Site of onset.

Age at onset.

Rate of progression.

Respiratory involvement.

Nutritional status.

Cognitive or behavioural involvement.

Response to supportive interventions.

Therefore, individual prognosis cannot be predicted accurately from onset pattern alone.

34. Motor Neurone Disease – Note Form

Disease: progressive neurodegenerative motor-system disorder.

ALS: common MND phenotype involving both UMN and LMN degeneration.

Structures involved: motor cortex/corticospinal tracts + anterior horn cells + motor brainstem nuclei.

UMN signs: spasticity, hyperreflexia, clonus and extensor plantars.

LMN signs: weakness, wasting, fasciculations and reduced reflexes in affected muscles.

Limb pattern: progressive weakness, often involving hands or distal limbs.

Foot drop: may occur from distal leg weakness.

Bulbar LMN signs: nasal/weak speech, tongue wasting/fasciculations, dysphagia.

Pseudobulbar UMN signs: spastic dysarthria, brisk jaw jerk and emotional lability.

Respiratory involvement: progressive respiratory muscle weakness and hypoventilation.

Sensation: usually preserved.

Diagnosis: primarily clinical.

EMG: demonstrates widespread denervation and reinnervation.

Nerve conduction studies: help exclude peripheral neuropathy; sensory conduction is usually relatively preserved.

Riluzole: modest disease-modifying survival benefit.

Spasticity treatment: baclofen, tizanidine or similar agents when appropriate.

Feeding support: PEG may be considered for progressive dysphagia and weight loss.

Respiratory support: non-invasive ventilation, usually bilevel support, is more appropriate than simple CPAP for hypoventilation.

Communication: computer, speech-generating and eye-gaze devices.

Care: multidisciplinary and increasingly palliative/supportive as disease progresses.

35. Characteristic Examination Pattern

A very characteristic examination finding is:

Muscle wasting + fasciculations + brisk reflexes + extensor plantars.

This shows simultaneous:

LMN degeneration → wasting and fasciculations.

and

UMN degeneration → hyperreflexia and extensor plantar responses.

When this occurs with progressive weakness and no significant sensory loss, MND becomes a major diagnostic consideration.

Key Clinical Pattern

Think of ALS/MND as:

Progressive MOTOR disease with BOTH UMN and LMN signs, but little or no sensory loss.

The classic pattern is:

Weakness + wasting + fasciculations + hyperreflexia/spasticity + extensor plantars.

Bulbar disease causes:

Dysarthria + dysphagia + aspiration risk.

Respiratory involvement causes:

Progressive hypoventilation and respiratory failure.

For treatment, remember:

Riluzole + symptom control + nutrition/PEG + non-invasive ventilation + communication support + multidisciplinary care.

And one important correction:

Respiratory muscle weakness in MND is usually managed with non-invasive bilevel ventilation rather than standard CPAP.

Medicine – Spastic Paraparesis

Spastic paraparesis means weakness of both lower limbs caused by an upper motor neurone lesion, usually affecting the corticospinal tracts in the spinal cord or, less commonly, bilateral cerebral motor pathways. The legs are weak and stiff, with increased tone and other pyramidal signs.

An asterisk (*) signifies a common cause.

1. Increased Tone

The characteristic motor abnormality is spasticity, meaning increased muscle tone that is velocity-dependent.

On examination, the legs may feel stiff when moved passively.

The increase in tone is usually more marked in the antigravity muscle groups.

2. Clonus

Clonus is a series of rhythmic involuntary muscle contractions triggered by sudden stretching of a muscle.

It is a sign of an upper motor neurone lesion.

A common example is:

Ankle clonus.

Sustained clonus strongly supports significant corticospinal tract dysfunction.

3. Weakness

Patients have weakness affecting both lower limbs.

The pattern depends on the level and severity of the lesion, but the weakness is usually accompanied by:

Spasticity.

Hyperreflexia.

Extensor plantar responses.

The legs may become stiff and difficult to move despite relatively preserved muscle bulk early in the disease.

4. Extensor Plantar Responses

An extensor plantar response, or positive Babinski sign, is an important pyramidal sign.

When the lateral sole is stimulated, the great toe extends upward and the other toes may fan.

Therefore:

Spastic paraparesis + extensor plantars → corticospinal tract involvement.

5. Hyperreflexia

Although not explicitly listed in the original notes, brisk deep tendon reflexes are usually expected in a pure upper motor neurone spastic paraparesis.

Typical findings include:

Brisk knee jerks.

Brisk ankle jerks.

Clonus.

However, reflexes may be reduced if a condition also damages peripheral nerves, such as subacute combined degeneration or Friedreich ataxia.

6. Atrophy and Contractures

Muscle wasting is not usually a prominent early feature of a pure upper motor neurone lesion.

However, chronic severe weakness and immobility may cause:

Disuse atrophy.

Muscle shortening.

Joint contractures.

Therefore, atrophy and contractures are generally late secondary changes, rather than primary features of corticospinal tract disease.

7. Gait

Patients may develop a characteristic spastic gait.

Features may include:

Stiff-legged walking.

Reduced knee flexion.

Scissoring of the legs in severe bilateral spasticity.

Difficulty lifting the feet.

Slow, effortful walking.

The exact gait varies with the underlying cause.

8. Multiple Sclerosis*

Multiple sclerosis is an important cause of spastic paraparesis, especially in younger adults.

Demyelinating plaques involving the spinal cord corticospinal tracts may produce:

Bilateral leg weakness.

Spasticity.

Hyperreflexia.

Extensor plantar responses.

Other MS manifestations may coexist, such as optic neuritis, sensory symptoms, bladder dysfunction, diplopia, or ataxia.

9. Cerebral Palsy*

Cerebral palsy can produce chronic spastic paraparesis when bilateral motor pathways controlling the lower limbs are affected.

A classic form is spastic diplegia, in which:

Both legs are more affected than the arms.

The patient may have:

Increased tone.

Scissoring gait.

Contractures.

Delayed motor development.

This is a non-progressive brain injury, although the musculoskeletal consequences can change over time.

10. Spinal Cord Compression*

Spinal cord compression is one of the most important causes of acquired spastic paraparesis.

Compression damages the corticospinal tracts and may also affect sensory and autonomic pathways.

Clinical features may include:

Back or neck pain.

Spastic leg weakness.

Sensory level.

Bladder or bowel dysfunction.

Hyperreflexia and extensor plantars.

Depending on the cause and progression, spinal cord compression may require urgent investigation.

11. Cervical or Thoracic Spondylosis

Spondylosis refers to degenerative changes of the spine.

When these changes narrow the spinal canal and compress the spinal cord, they may produce degenerative cervical myelopathy or, less commonly, thoracic cord compression.

The patient may develop:

Spastic leg weakness.

Gait difficulty.

Hand clumsiness if the cervical cord is involved.

Brisk reflexes.

Extensor plantar responses.

12. Neoplasia

Tumours can cause spastic paraparesis through compression or infiltration of the spinal cord.

Possible causes include:

Metastatic vertebral disease.

Epidural tumour.

Primary spinal tumour.

Intramedullary tumour.

A history of cancer together with new back pain and progressive leg weakness should raise concern for metastatic spinal cord compression.

13. Disc Prolapse

A large intervertebral disc prolapse may compress the spinal cord if it occurs at a level where the spinal cord is present, particularly in the cervical or thoracic spine.

This can produce:

Spastic paraparesis below the lesion.

By contrast, a lumbar disc prolapse below the conus more commonly compresses nerve roots and causes cauda equina or radicular LMN signs rather than spastic paraparesis.

14. Motor Neurone Disease

Motor neurone disease, particularly amyotrophic lateral sclerosis, can cause a mixture of upper and lower motor neurone findings.

If corticospinal tract involvement is prominent in the lower limbs, the patient may develop:

Spastic paraparesis.

However, additional findings such as:

Muscle wasting.

Fasciculations.

Bulbar weakness.

may suggest combined LMN involvement.

15. Spinal Cord Infarction

Spinal cord infarction may cause sudden or rapidly developing bilateral leg weakness.

The clinical pattern depends on which vascular territory is affected.

Anterior spinal artery infarction may produce:

Motor weakness.

Loss of pain and temperature below the lesion.

with relative preservation of:

Vibration and proprioception, at least initially.

Spasticity may develop after the acute spinal shock phase.

16. Vasculitis

Systemic or central nervous system vasculitis can damage the spinal cord through inflammatory vascular injury and ischaemia.

This may produce a myelopathy with:

Spastic paraparesis.

Sensory abnormalities.

Sphincter dysfunction.

Other systemic inflammatory features may provide clues to the diagnosis.

17. Myelitis

Myelitis means inflammation of the spinal cord.

A common clinical syndrome is transverse myelitis.

Patients may develop:

Bilateral weakness.

Sensory level.

Bladder or bowel dysfunction.

Initially reduced reflexes in spinal shock, followed later by spasticity and hyperreflexia.

Causes include autoimmune disease, infection, demyelinating disease, and idiopathic inflammatory myelopathy.

18. Subacute Combined Degeneration

Subacute combined degeneration due to vitamin B12 deficiency affects the:

Dorsal columns.

Corticospinal tracts.

Peripheral nerves.

It can therefore produce:

Spastic paraparesis.

Sensory ataxia.

Loss of vibration and proprioception.

Peripheral neuropathy.

Extensor plantar responses.

Reflexes may paradoxically be reduced because of simultaneous peripheral nerve damage.

19. Friedreich Ataxia

Friedreich ataxia can also produce pyramidal tract involvement and spastic weakness of the legs.

However, the clinical picture is mixed and usually includes:

Progressive ataxia.

Peripheral sensory neuropathy.

Pes cavus.

Kyphoscoliosis.

Absent tendon reflexes.

Extensor plantar responses.

Cardiomyopathy.

Therefore, it is not a simple pure spastic paraparesis.

20. Syringomyelia

Syringomyelia is formation of a fluid-filled cavity, or syrinx, within the spinal cord.

Classically, it causes:

Loss of pain and temperature in a cape-like distribution.

Preserved vibration and proprioception early.

Lower motor neurone weakness at the level of the lesion.

If the syrinx expands and damages corticospinal tracts, it can eventually produce:

Spastic weakness of the legs below the lesion.

21. Syphilis

Neurosyphilis can affect the spinal cord in several ways.

The classic form tabes dorsalis primarily damages the dorsal columns and dorsal roots, producing sensory ataxia and reduced reflexes rather than a typical spastic paraparesis.

However, other syphilitic forms, such as meningovascular or meningomyelitic disease, can involve corticospinal pathways and cause spastic weakness.

Therefore, syphilis is a less common and more context-dependent cause.

22. Spastic Paraparesis – Note Form

Definition: bilateral lower-limb weakness with upper motor neurone signs.

Tone: increased.

Reflexes: usually brisk.

Clonus: may be present.

Plantar responses: extensor.

Weakness: both legs.

Atrophy: usually secondary to chronic disuse rather than an early primary feature.

Contractures: may develop in chronic severe spasticity.

*Common demyelinating cause: ** multiple sclerosis.

*Common developmental cause: ** cerebral palsy, especially spastic diplegia.

*Common structural cause: ** spinal cord compression.

Cord compression causes: spondylosis, tumour and disc prolapse.

Other causes: motor neurone disease, spinal cord infarction, vasculitis, myelitis, subacute combined degeneration, Friedreich ataxia, syringomyelia and neurosyphilis.

23. Useful Localisation Clues

Spastic paraparesis + sensory level → spinal cord lesion likely.

Spastic paraparesis + bladder dysfunction → spinal cord disease particularly important.

Spastic paraparesis + optic neuritis/other disseminated neurological episodes → consider MS.

Spastic paraparesis + loss of vibration/proprioception + neuropathy → consider vitamin B12 deficiency.

Spastic paraparesis + ataxia + pes cavus + cardiomyopathy → consider Friedreich ataxia.

Spastic paraparesis + cape-like pain/temperature loss → consider syringomyelia.

Key Clinical Pattern

Think of spastic paraparesis as:

Bilateral leg weakness + increased tone + hyperreflexia/clonus + extensor plantar responses.

The major categories are:

Demyelinating → MS.

Developmental → cerebral palsy.

Compressive → spondylosis, tumour, disc disease.

Inflammatory/vascular → myelitis, vasculitis, spinal cord infarction.

Metabolic/hereditary → B12 deficiency, Friedreich ataxia.

A particularly important clinical rule is:

Spastic paraparesis with a sensory level or new bladder/bowel dysfunction should prompt urgent consideration of spinal cord compression or another myelopathy.

Medicine – Subacute Combined Degeneration of the Spinal Cord

Subacute combined degeneration of the spinal cord is a neurological complication most commonly caused by vitamin B12 deficiency. It affects multiple neurological pathways at the same time, particularly the dorsal columns and corticospinal tracts, and is often accompanied by peripheral neuropathy.

The term combined degeneration refers to simultaneous involvement of more than one major spinal cord pathway.

1. Main Cause

The classic cause is:

Vitamin B12 deficiency.

Vitamin B12 is essential for normal myelin maintenance and nervous-system function.

Deficiency can lead to progressive demyelination and axonal injury involving the spinal cord and peripheral nerves.

2. Common Causes of Vitamin B12 Deficiency

Important causes include:

Pernicious anaemia.

Malabsorption, including terminal ileal disease.

Previous gastric or ileal surgery.

Strict vegan diet without adequate supplementation.

Certain medications, such as long-term metformin or acid-suppressing therapy in some patients.

Nitrous oxide exposure, which can functionally inactivate vitamin B12.

3. Pathways Affected

The major neurological structures affected are:

Dorsal columns.

Lateral corticospinal tracts.

Peripheral nerves.

This combination explains the apparently mixed neurological findings.

4. Dorsal Column Involvement

The dorsal columns carry:

Vibration sensation.

Joint-position sense.

Fine discriminative touch.

Damage therefore causes loss of proprioceptive input from the limbs.

The patient may become unsteady, particularly when visual compensation is removed.

5. Sensory Ataxia

Loss of proprioception from dorsal-column disease produces sensory ataxia.

Patients may describe:

Unsteady walking.

Difficulty walking in the dark.

A feeling that they do not know where their feet are.

Examination may show:

Loss of vibration sense.

Loss of joint-position sense.

Positive Romberg test.

6. Positive Romberg Test

A patient with sensory ataxia may maintain balance while the eyes are open because vision compensates for impaired proprioception.

When the eyes are closed, this visual compensation is removed and the patient becomes markedly more unstable.

Therefore:

Dorsal-column disease → sensory ataxia → positive Romberg sign.

7. Peripheral Neuropathy

Vitamin B12 deficiency can also damage peripheral nerves.

This often causes symmetrical distal sensory symptoms in a:

Glove-and-stocking distribution.

Patients may develop:

Numbness.

Tingling.

Burning or altered sensation.

Distal weakness in more advanced disease.

8. Glove-and-Stocking Sensory Loss

A glove-and-stocking pattern means that sensory loss begins distally in the:

Feet and lower legs.

and later, if more severe, the:

Hands.

This pattern reflects a length-dependent peripheral neuropathy rather than isolated spinal cord disease.

9. Corticospinal Tract Involvement

The lateral corticospinal tracts carry upper motor neurone motor fibres.

Damage can therefore produce:

Spasticity.

Increased muscle tone.

Weakness of the legs.

Extensor plantar responses.

The lower limbs are commonly affected more prominently than the upper limbs.

10. Spastic Paraparesis

Bilateral corticospinal tract involvement may cause spastic paraparesis.

This means:

Weakness of both legs + increased tone + pyramidal signs.

Patients may develop a stiff, difficult gait as the disease progresses.

11. Absent Reflexes

One of the characteristic features of subacute combined degeneration is that tendon reflexes may be reduced or absent, especially at the ankles.

This occurs because of the accompanying peripheral neuropathy.

Therefore, even though corticospinal tract disease usually increases reflexes, peripheral nerve damage can reduce the reflex arc.

12. Extensor Plantar Responses

The plantar responses may be extensor, or Babinski positive.

This reflects corticospinal tract involvement.

Thus a classic apparently paradoxical combination may occur:

Absent ankle reflexes + extensor plantar responses.

13. Why Absent Reflexes and Extensor Plantars Can Coexist

These findings arise from damage at different levels.

Peripheral neuropathy → reduced/absent tendon reflexes.

Corticospinal tract damage → extensor plantar responses.

Therefore, the combination does not contradict itself.

It is actually a useful clue to a disorder affecting both peripheral nerves and central motor pathways.

14. Other Neurological Features

Additional manifestations of vitamin B12 deficiency can include:

Weakness.

Paraesthesia.

Gait disturbance.

Cognitive changes.

Mood disturbance.

Optic neuropathy in some cases.

Severe untreated deficiency can lead to permanent neurological damage.

15. Haematological Features

Vitamin B12 deficiency may also cause:

Macrocytic anaemia.

Macro-ovalocytes.

Hypersegmented neutrophils.

However, important neurological disease can occur even when anaemia is mild or absent.

Therefore:

Normal haemoglobin does not exclude neurological vitamin B12 deficiency.

16. Investigations

Useful investigations include:

Serum vitamin B12.

Full blood count and MCV.

Blood film.

Methylmalonic acid, which often rises in B12 deficiency.

Homocysteine, which may also be elevated.

Further testing should investigate the underlying cause, such as pernicious anaemia or malabsorption.

17. Pernicious Anaemia

Pernicious anaemia is an autoimmune cause of vitamin B12 deficiency.

Autoimmune destruction of gastric parietal cells leads to reduced intrinsic factor, impairing absorption of vitamin B12 in the terminal ileum.

Testing may include:

Intrinsic-factor antibodies.

Other autoimmune gastric markers may also support the diagnosis.

18. Treatment

Treatment requires vitamin B12 replacement.

When neurological involvement is present, treatment should not be delayed unnecessarily because prolonged deficiency may cause irreversible deficits.

Replacement is often given parenterally initially, depending on the cause and severity of deficiency.

The underlying cause should also be identified and treated where possible.

19. Important Folate Warning

Folate can improve the anaemia caused by vitamin B12 deficiency without correcting the neurological injury.

Therefore, giving folate alone to someone with unrecognised B12 deficiency may allow neurological disease to continue.

For this reason:

Vitamin B12 deficiency should be excluded or treated when clinically suspected before relying on folate replacement alone.

20. Subacute Combined Degeneration – Note Form

Cause: vitamin B12 deficiency.

Main spinal pathways affected: dorsal columns + corticospinal tracts.

Additional involvement: peripheral nerves.

Dorsal-column damage: loss of vibration and joint-position sense.

Clinical result: sensory ataxia and positive Romberg test.

Peripheral neuropathy: glove-and-stocking sensory loss.

Corticospinal damage: spastic paraparesis and extensor plantar responses.

Reflexes: may be absent because peripheral neuropathy interrupts the reflex arc.

Characteristic mixed pattern: absent reflexes + extensor plantars.

21. Characteristic Examination Pattern

A typical neurological examination may show:

Loss of vibration and proprioception.

Sensory ataxia.

Positive Romberg sign.

Distal glove-and-stocking sensory loss.

Spastic weakness of both legs.

Reduced or absent ankle reflexes.

Extensor plantar responses.

This combination strongly suggests simultaneous involvement of dorsal columns, peripheral nerves and corticospinal tracts.

Key Clinical Pattern

Think of subacute combined degeneration as:

Vitamin B12 deficiency → DORSAL COLUMNS + CORTICOSPINAL TRACTS + PERIPHERAL NERVES.

Therefore:

Dorsal columns → sensory ataxia + loss of vibration/proprioception.

Peripheral nerves → glove-and-stocking neuropathy + absent reflexes.

Corticospinal tracts → spastic paraparesis + extensor plantars.

The high-yield combination is:

Sensory ataxia + peripheral neuropathy + spastic paraparesis + absent reflexes + extensor plantar responses.

Medicine – Cauda Equina Lesions

Cauda equina lesions result from compression or damage to the bundle of lumbosacral nerve roots below the termination of the spinal cord. The cauda equina contains nerve roots that supply the lower limbs as well as sensory and autonomic fibres controlling the bladder, bowel, and sexual function.

Severe compression produces cauda equina syndrome (CES), which is a neurological and spinal surgical emergency because delayed decompression may result in permanent weakness, sensory loss, and bladder or bowel dysfunction.

1. Anatomy of the Cauda Equina

In adults, the spinal cord usually terminates around the L1–L2 vertebral level as the conus medullaris.

Below this level, the lumbar, sacral, and coccygeal nerve roots descend within the spinal canal before leaving through their respective foramina.

This collection of nerve roots resembles a horse’s tail and is therefore called the:

Cauda equina.

2. Nature of the Neurological Lesion

The cauda equina consists of peripheral nerve roots, so damage generally produces lower motor neurone-type abnormalities rather than the upper motor neurone signs expected from spinal cord compression.

Patients may therefore develop:

Flaccid weakness.

Reduced muscle tone.

Reduced or absent tendon reflexes.

Muscle weakness in a nerve-root distribution.

However, the exact findings depend on which roots are compressed.

3. Bilateral Leg Weakness

Cauda equina compression can produce weakness of both lower limbs.

The weakness may be asymmetric, especially early in the disease, because individual nerve roots can be affected to different degrees.

Therefore, although bilateral weakness is characteristic of extensive cauda equina compression:

Cauda equina weakness does not have to be perfectly symmetrical.

4. Weakness Most Marked at the Ankles

Weakness may be particularly prominent distally because the lower lumbar and sacral nerve roots supplying the ankle and foot can be heavily affected.

Patients may have difficulty with:

Ankle dorsiflexion.

Ankle plantarflexion.

Toe movements.

This may produce:

Foot drop.

Difficulty walking on the heels.

Difficulty walking on the toes.

The exact pattern depends on the affected nerve roots.

5. Sensory Loss and Numbness

Patients frequently develop numbness, tingling, or reduced sensation in the lower limbs.

Because multiple nerve roots may be involved, sensory abnormalities can occur in several dermatomes rather than following a single peripheral nerve.

One of the most important patterns is sensory loss in the sacral distribution.

6. Saddle Anaesthesia

Compression of the lower sacral roots can cause sensory loss around the:

Perineum.

Perianal region.

Genital region.

Inner thighs.

This distribution corresponds approximately to the area that would contact a saddle and is therefore called:

Saddle anaesthesia.

This is a major warning sign of cauda equina syndrome.

7. Sacral Sensory Loss

The original description that sensory loss is most marked in the sacral region refers particularly to involvement of the sacral nerve roots.

Patients should be asked specifically about:

Numbness around the anus.

Altered sensation when wiping after using the toilet.

Perineal or genital numbness.

These symptoms can be more clinically important than ordinary leg numbness.

8. Loss of Bladder Control

Damage to the sacral autonomic roots can interfere with bladder function.

A particularly concerning feature is:

Difficulty initiating urination or urinary retention.

The patient may lose the normal sensation of bladder filling.

As retention progresses, an overfilled bladder may eventually produce overflow urinary incontinence.

Therefore, urinary dysfunction in cauda equina syndrome is not simply incontinence.

A particularly important progression is:

Reduced bladder sensation → difficulty voiding → urinary retention → overflow incontinence.

9. Bowel Dysfunction

Sacral nerve-root compression can also interfere with bowel control.

Patients may develop:

Reduced sensation of rectal fullness.

Constipation.

Reduced anal sphincter control.

Faecal incontinence in severe disease.

These findings suggest significant sacral nerve-root dysfunction.

10. Sexual Dysfunction

The sacral nerve roots also participate in sexual function.

Cauda equina syndrome may therefore produce:

Erectile dysfunction.

Reduced genital sensation.

Other disturbances of sexual function.

This can provide another clue to sacral nerve-root involvement.

11. Lower Motor Neurone Signs

Because the cauda equina consists of nerve roots rather than spinal cord tissue, the affected legs may demonstrate:

Reduced tone.

Reduced or absent reflexes.

Flaccid weakness.

For example, involvement of the S1 nerve roots may reduce or abolish the ankle jerk.

12. Radicular Pain

Severe low-back pain with radicular leg pain commonly accompanies cauda equina compression.

Pain may radiate down one or both legs according to the affected nerve roots.

However, absence of severe pain does not completely exclude cauda equina syndrome.

13. Central Lumbar Disc Prolapse

A large central lumbar intervertebral disc prolapse is one of the most important causes of acute cauda equina syndrome.

A small posterolateral disc prolapse may compress only one nerve root and cause ordinary sciatica.

In contrast, a sufficiently large central disc prolapse can compress multiple cauda equina roots simultaneously.

Therefore:

Large central lumbar disc prolapse → multiple root compression → cauda equina syndrome.

14. Degenerative Spondylolisthesis

The original note uses the term spondylolithiasis, but the appropriate term here is usually spondylolisthesis.

Spondylolisthesis means displacement of one vertebra relative to another.

Degenerative changes can narrow the spinal canal and compress the cauda equina, particularly when associated with spinal stenosis.

15. Tumours

Tumours can cause cauda equina syndrome by compressing the lumbosacral nerve roots.

Compression may result from:

Metastatic disease.

Primary spinal tumours.

Tumours involving vertebral structures.

Epidural masses.

Tumours arising around the nerve roots.

Therefore, the important concept is mechanical compression of the cauda equina, rather than assuming that all tumours are necessarily external to the spinal canal.

16. Spinal Stenosis

Lumbar spinal stenosis is narrowing of the spinal canal, commonly due to degenerative changes.

Causes of narrowing may include:

Facet-joint hypertrophy.

Ligamentous thickening.

Disc degeneration or bulging.

Spondylolisthesis.

Severe stenosis can compress multiple cauda equina nerve roots.

Chronic lumbar stenosis more commonly causes neurogenic claudication, but severe compression can occasionally produce cauda equina syndrome.

17. Other Important Causes

Although not included in the original list, other clinically important causes include:

Spinal epidural abscess.

Spinal epidural haematoma.

Severe spinal trauma.

Postoperative or procedural complications.

These are important because some can produce rapidly progressive compression requiring emergency treatment.

18. Red-Flag Symptoms

The combination of back or radicular pain with new neurological abnormalities should raise concern for cauda equina syndrome.

Particularly important red flags are:

New urinary retention or impaired bladder sensation.

Saddle or perineal sensory loss.

New bowel dysfunction.

Bilateral or progressive leg weakness.

Sexual dysfunction.

These findings require urgent assessment.

19. Investigation

When cauda equina syndrome is suspected, the key investigation is generally an urgent MRI of the lumbosacral spine.

MRI can identify:

Large disc prolapse.

Spinal stenosis.

Tumour.

Epidural abscess or haematoma.

Other compressive lesions.

Bladder assessment, including measurement of post-void residual volume, can provide useful additional information but does not replace appropriate neurological assessment and imaging.

20. Treatment

Management depends on the underlying cause, but compressive cauda equina syndrome generally requires urgent specialist spinal assessment and decompression when indicated.

Examples include:

Surgical decompression of a large disc prolapse.

Treatment of spinal tumour compression.

Drainage and antimicrobial therapy for an epidural abscess.

Management of an epidural haematoma.

The aim is to relieve nerve-root compression before irreversible neurological damage develops.

21. Cauda Equina Lesions – Note Form

Site: lumbosacral nerve roots below the spinal cord.

Motor: bilateral or asymmetric lower-limb weakness.

Type of weakness: lower motor neurone pattern.

Distal weakness: may be prominent at the ankles and feet.

Reflexes: reduced or absent depending on the affected roots.

Sensation: lower-limb numbness with important sacral/perineal sensory loss.

Classic sensory sign: saddle anaesthesia.

Bladder: impaired bladder sensation and urinary retention are particularly important.

Late bladder manifestation: overflow incontinence may occur.

Bowel: impaired bowel sensation/control ± faecal incontinence.

Sexual function: may be impaired.

Disc cause: large central lumbar disc prolapse.

Degenerative cause: lumbar spinal stenosis ± degenerative spondylolisthesis.

Tumour: may compress the cauda equina.

Other emergencies: epidural abscess, epidural haematoma and major trauma.

22. Cauda Equina Syndrome versus Simple Sciatica

Simple radiculopathy/sciatica usually involves one or a small number of nerve roots and commonly produces unilateral radicular pain ± focal weakness or sensory loss.

In contrast, cauda equina syndrome involves multiple lumbosacral roots and may produce:

Saddle anaesthesia + bladder/bowel dysfunction + bilateral or progressive neurological deficits.

These autonomic and sacral sensory findings make cauda equina syndrome much more concerning.

Key Clinical Pattern

Think of cauda equina syndrome as:

Multiple lumbosacral nerve-root compression → LMN leg weakness + saddle anaesthesia + sphincter/autonomic dysfunction.

The classic high-yield combination is:

Back/radicular pain + bilateral or progressive leg weakness + saddle anaesthesia + urinary dysfunction.

Important causes are:

Large central lumbar disc prolapse + severe spinal stenosis/spondylolisthesis + tumour + epidural abscess or haematoma.

Most importantly:

New urinary retention or impaired bladder sensation with saddle anaesthesia is an emergency pattern requiring urgent assessment for cauda equina compression.

Infectious Disease and Microbiology – Trichostrongylus Species

Overview

Trichostrongylus species are nematode helminths that primarily infect herbivorous animals but can occasionally infect humans. Human infection is generally acquired in rural settings where livestock are raised and environmental contamination with animal feces occurs.

Most infections are asymptomatic, but heavier worm burdens can produce mild gastrointestinal symptoms and sometimes anemia.

Classification

Genus: Trichostrongylus

Important species include:

• Trichostrongylus orientalis

• Trichostrongylus colubriformis

Organism: Nematode helminth

Microbiologic Characteristics

Trichostrongylus species are:

• Intestinal nematodes

• Parasites commonly associated with herbivorous animals

• Zoonotic helminths capable of infecting humans

• Organisms whose eggs may resemble hookworm eggs on stool microscopy

High-Yield Microbiology Pattern

Nematode

• ●

Rural livestock exposure

• ●

Mild GI symptoms or anemia

• ●

Large hookworm-like eggs in stool

→ Think TRICHOSTRONGYLUS

Incubation Period

The incubation period is:

Unclear

Clinical manifestations depend more on:

Worm burden and host factors

than on a precisely defined incubation interval.

Epidemiology

Trichostrongylus species have a:

Worldwide distribution

Human infection is more common in:

Rural agricultural communities

especially where:

• Sheep are raised

• Goats are raised

• Cattle or other herbivores are present

• Animal feces contaminate soil or vegetation

Reservoir

The major reservoirs are:

Herbivorous animals

including livestock.

Humans are:

Accidental hosts

rather than the principal reservoir.

Transmission

Human infection occurs after ingestion of:

Infective larvae from contaminated food or vegetation

The environmental cycle is maintained when animal feces contaminate:

Soil and plants

High-Yield Exposure Pattern

Rural area

• ●

Livestock/herbivore exposure

• ●

Contaminated raw vegetables

→ Possible Trichostrongylus infection

Life Cycle

Eggs are passed in the feces of infected animals.

↓

Larvae develop in the environment.

↓

Infective larvae contaminate:

Soil, grass, or vegetables

↓

Humans accidentally ingest the larvae.

↓

Adult worms develop in the:

Small intestine

↓

Eggs are eventually passed in human stool.

Clinical Infection

Most infections are:

ASYMPTOMATIC

especially when the parasite burden is low.

Gastrointestinal Manifestations

Symptomatic patients may develop:

• Dyspepsia

• Abdominal discomfort

• Nausea

• Diarrhea

• Reduced appetite

These symptoms are generally:

Mild

Anemia

The source notes that infection may occasionally cause:

ANEMIA

particularly with heavier parasite burdens.

The anemia tends to reflect intestinal parasitism and chronic nutritional or blood-loss effects.

Eosinophilia

As with many tissue or intestinal helminth infections, some patients may develop:

Peripheral eosinophilia

although this is not the defining diagnostic feature.

High-Yield Clinical Pattern

Rural livestock exposure

• ●

Mild abdominal symptoms

• ●

Anemia

• ●

Hookworm-like eggs that are unusually large

→ Think TRICHOSTRONGYLUS

Diagnosis

The primary diagnostic method is:

PARASITOLOGIC EXAMINATION OF STOOL

Stool microscopy demonstrates:

Characteristic nematode eggs

Egg Morphology

An important diagnostic point is that:

Trichostrongylus eggs resemble hookworm eggs

However:

TRICHOSTRONGYLUS EGGS ARE GENERALLY LARGER

This is a classic parasitology distinction.

High-Yield Egg Comparison

Trichostrongylus

→ Thin-shelled oval egg

→ Resembles hookworm

→ Usually larger

→ Often more elongated

Hookworm

→ Thin-shelled oval egg

→ Generally smaller

→ Commonly associated with Necator or Ancylostoma

Stool Identification

Species-level identification may sometimes be difficult using eggs alone because of:

Morphologic similarity among nematodes

Additional parasitologic expertise or larval identification may occasionally be required.

Treatment

The source lists:

MEBENDAZOLE

as the primary treatment.

Additional Treatment

The source also lists:

ALBENDAZOLE 400 mg orally as a single dose

as an alternative therapy.

Supportive Management

If clinically significant anemia is present, management may also include:

Assessment and correction of iron deficiency or other nutritional abnormalities

depending on the patient’s findings.

Prevention

Prevention focuses on reducing ingestion of infective larvae.

Important measures include:

• Thoroughly washing raw vegetables

• Avoiding produce contaminated with animal feces

• Good hand hygiene after handling livestock or soil

• Proper disposal of animal feces

• Improved sanitation around farms

• Veterinary parasite control in livestock

Trichostrongylus vs. Hookworm

This is the most important examination comparison.

Trichostrongylus

→ Usually acquired by ingestion

→ Associated with herbivorous livestock

→ Mild intestinal disease

→ Eggs resemble hookworm eggs but are larger

Hookworm

→ Necator americanus / Ancylostoma duodenale

→ Infective larvae usually penetrate skin

→ Ground itch

→ Pulmonary migration

→ Iron-deficiency anemia

→ Smaller hookworm-type eggs

High-Yield Distinction

Barefoot soil exposure + ground itch + anemia

→ Hookworm

Livestock exposure + contaminated vegetables + large hookworm-like eggs

→ Trichostrongylus

Trichostrongylus vs. Strongyloides

Trichostrongylus

→ Acquired by ingestion

→ Eggs may be detected in stool

→ No clinically important autoinfection cycle

Strongyloides stercoralis

→ Larvae penetrate skin

→ Larvae, rather than eggs, are usually detected in stool

→ Autoinfection can occur

→ Hyperinfection possible with immunosuppression

Trichostrongylus vs. Trichuris

Trichostrongylus

→ Hookworm-like oval eggs

→ Small-intestinal nematode

→ Livestock-associated zoonosis

Trichuris trichiura

→ Barrel/lemon-shaped eggs with bipolar plugs

→ Large-intestinal infection

→ Heavy disease may cause dysentery and rectal prolapse

High-Yield Clinical Pattern

Rural agricultural setting

• ●

Sheep/goats/cattle exposure

• ●

Mild GI symptoms ± anemia

• ●

Large hookworm-like eggs in stool

→ Think TRICHOSTRONGYLUS

Exam Essentials

Genus: Trichostrongylus

Important species: T. orientalis and T. colubriformis

Organism: Nematode helminth

Distribution: Worldwide

Major setting: Rural livestock-raising regions

Reservoir: Herbivorous animals

Transmission: Ingestion of infective larvae from contaminated vegetation/food

Typical infection: Usually asymptomatic

Symptoms: Mild dyspepsia or other GI complaints

Possible complication: Anemia

Diagnosis: Stool parasitology

Egg appearance: Similar to hookworm eggs but usually larger

Treatment: Mebendazole

Alternative: Albendazole 400 mg orally as a single dose

Prevention: Food washing, sanitation, and reduced fecal contamination from livestock

Memory Aid

TRICHOSTRONGYLUS = STRONG LIVESTOCK CONNECTION

Think:

Rural livestock

• ●

Raw contaminated vegetables

• ●

Large hookworm-like eggs

→ Trichostrongylus

And:

TRICHO-STRONG = BIGGER THAN HOOKWORM EGGS

Key clinical pearl: Trichostrongylus species are zoonotic intestinal nematodes associated with herbivorous livestock and rural environments. Most human infections are asymptomatic, but heavier infections can cause mild gastrointestinal symptoms and anemia. Diagnosis is made by stool microscopy, with the key parasitologic clue being eggs that resemble hookworm eggs but are usually larger.